Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v3-EN
Language English English
Date Updated 2022-10-31 2022-10-04
Drug Identification Number 02172739 02172739
Brand name OMNIPAQUE 240 OMNIPAQUE 240
Common or Proper name iohexol injection USP iohexol injection USP
Company Name GE HEALTHCARE CANADA INC GE HEALTHCARE CANADA INC
Ingredients IOHEXOL IOHEXOL
Strength(s) 518MG 518MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVASCULAR SUBARACHNOIDAL INTRAVASCULAR SUBARACHNOIDAL INTRAVASCULAR SUBARACHNOIDAL INTRAVASCULAR SUBARACHNOIDAL
Packaging size 20 mL 20 mL
ATC code V08AB V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-10-05 2022-10-05
Actual start date 2022-10-04 2022-10-04
Estimated end date 2022-10-31 2022-10-28
Actual end date 2022-10-31
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments